# Chongqing Medical University

Organization · id `cardio:org-chongqing-medical-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 017z00e58](<https://ror.org/017z00e58>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 017z00e58 by an exact name.

## The registry's words

- Sponsor name: Chongqing Medical University
- Sponsor class: OTHER
- ROR name: Chongqing Medical University

## Connected pages

- Sponsors: Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety (`cardio:ct-nct03667677`)
- Sponsors: Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China (`cardio:ct-nct04762472`)
- Sponsors: Finerenone for Patients With Primary Aldosteronism (FAIRY) (`cardio:ct-nct06457074`)

## Provenance

Content hash: 1b253491f53e1b0acc1d9eb2329a3a841103beeaf7104fa6c6f4d44c2f443187
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
